
MoonLake (MLTX) Stock: Upcoming Phase 2 Results A Major Catalyst
Klaus Vedfelt/DigitalVision via Getty Images Investment Overview IL-17 – A Drug Target To Rival IL-23 / Skyrizi? Yesterday the Pharma giant AbbVie (ABBV) reported its FY22 earnings and provided guidance for 2023, which included a […]